PMID- 30125564 OWN - NLM STAT- MEDLINE DCOM- 20181227 LR - 20181227 IS - 1879-0712 (Electronic) IS - 0014-2999 (Linking) VI - 836 DP - 2018 Oct 5 TI - The dorsal hippocampal group III metabotropic glutamate receptors are involved in morphine effect on memory formation in male mice. PG - 44-49 LID - S0014-2999(18)30476-X [pii] LID - 10.1016/j.ejphar.2018.08.023 [doi] AB - This study investigated the role of dorsal hippocampal (CA1) group III metabotropic glutamate (mGlu) receptors in impairment of memory formation and state-dependent memory induced by morphine. For this purpose, the CA1 area was cannulated and one-trial passive avoidance task was selected to assess the memory function. Morphine was administrated subcutaneously (s.c.) and mGlu receptors agonist or antagonist were microinjected into CA1 regions. The obtained results indicated that pre-training administration of morphine (5 mg/kg; s.c.) decreased memory retention. Moreover, pre-test administration of morphine (5 mg/kg; s.c.) induced morphine state-dependent memory retention under pre-training morphine effect (5 mg/kg; s.c.). Although, intra-CA1 microinjection of lower doses of group III mGlu receptors agonist, L-AP4, (10 and 20 mmol/mouse) and antagonist, CPPG, (10 and 15 mmol/mouse) did not affect memory retention, but higher dose of the drugs (30 mmol/mouse) decreased memory retention. Pre-test microinjection of L-AP4 (10, 20 and 30 mmol/mouse; intra-CA1) had no effect on morphine-induced amnesia, but same doses of L-AP4 plus an effective dose of morphine (1 mg/kg; s.c.) reversed morphine-induced amnesia. Interestingly, amnesia induced by pre-training morphine (5 mg/kg; s.c.) was significantly reversed by pre-test administration of CPPG (30 mmol/mouse; intra-CA1). On the other hand, pre-test co-administration of CPPG (10 and 15 mmol/mouse; intra-CA1) and morphine (5 mg/kg; s.c.) following pre-training morphine (5 mg/kg; s.c.) decreased memory retention. Taken together, our results suggested that morphine effects on memory formation might be mediated via the activity of dorsal hippocampal metabotropic glutamate receptors. CI - Copyright (c) 2018 Elsevier B.V. All rights reserved. FAU - Alijanpour, Sakineh AU - Alijanpour S AD - Department of Biology, Faculty of Science, Gonbad Kavous University, Gonbad Kavous, Iran. Electronic address: Alijanpour@gonbad.ac.ir. FAU - Arabi-Shirazi, Ameneh AU - Arabi-Shirazi A AD - Department of Biology, Tehran North branch, Islamic Azad University, Tehran, Iran. FAU - Khakpai, Fatemeh AU - Khakpai F AD - Cognitive and Neuroscience Research Center (CNRC), Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran. FAU - Zarrindast, Mohammad-Reza AU - Zarrindast MR AD - Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. FAU - Sharifi, Khadijeh-Alsadat AU - Sharifi KA AD - Department of Neuroscience, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. LA - eng PT - Journal Article DEP - 20180818 PL - Netherlands TA - Eur J Pharmacol JT - European journal of pharmacology JID - 1254354 RN - 0 (2-amino-4-phosphono-propinate) RN - 0 (Propionates) RN - 0 (Receptors, Metabotropic Glutamate) RN - 0 (cyclopropyl-4-phosphonophenylglycine) RN - 76I7G6D29C (Morphine) RN - TE7660XO1C (Glycine) SB - IM MH - Animals MH - Glycine/analogs & derivatives/pharmacology MH - Hippocampus/drug effects/*metabolism/physiology MH - Male MH - Memory/*drug effects MH - Mice MH - Morphine/*pharmacology MH - Propionates/pharmacology MH - Receptors, Metabotropic Glutamate/*metabolism OTO - NOTNLM OT - CPPG OT - L-AP4 OT - Memory retention OT - Mice OT - Morphine EDAT- 2018/08/21 06:00 MHDA- 2018/12/28 06:00 CRDT- 2018/08/21 06:00 PHST- 2018/04/22 00:00 [received] PHST- 2018/07/21 00:00 [revised] PHST- 2018/08/16 00:00 [accepted] PHST- 2018/08/21 06:00 [pubmed] PHST- 2018/12/28 06:00 [medline] PHST- 2018/08/21 06:00 [entrez] AID - S0014-2999(18)30476-X [pii] AID - 10.1016/j.ejphar.2018.08.023 [doi] PST - ppublish SO - Eur J Pharmacol. 2018 Oct 5;836:44-49. doi: 10.1016/j.ejphar.2018.08.023. Epub 2018 Aug 18.